Skip to main content

Alpha-N-acetylgalactosaminidase deficiency

Alpha-N-acetylgalactosaminidase deficiency, also known as Schindler disease, is an inherited disorder that can affect the development of the nervous system. People with alpha-N-acetylgalactosaminidase deficiency often have distinctive facial features that can be described as "coarse" and tooth abnormalities such as widely-spaced teeth and missing teeth (hypodontia).

Description

Alpha-N-acetylgalactosaminidase deficiency, also known as Schindler disease, is an inherited disorder that can affect the development of the nervous system. People with alpha-N-acetylgalactosaminidase deficiency often have distinctive facial features that can be described as "coarse" and tooth abnormalities such as widely-spaced teeth and missing teeth (hypodontia).

The three types of alpha-N-acetylgalactosaminidase deficiency differ in the severity of their signs and symptoms and the age at which they first appear. The signs and symptoms of alpha-N-acetylgalactosaminidase deficiency can vary, even among members of the same family. 

Type I is the most severe form of this condition. Babies with alpha-N-acetylgalactosaminidase deficiency type I appear healthy at birth. However, by late infancy, these babies typically have trouble meeting normal developmental milestones. By the age of 2 years, individuals with type I begin to lose skills that they had already acquired (developmental regression). Individuals with type I often experience weak muscle tone (hypotonia), vision and hearing loss, and seizures. During early childhood, children with type I typically lose awareness of their surroundings and eventually become unresponsive.

Alpha-N-acetylgalactosaminidase deficiency type II is the least severe form. Type II is typically diagnosed in adulthood. Affected individuals may have mild cognitive impairment and hearing loss caused by abnormalities of the inner ear (sensorineural hearing loss). They may also experience a loss of sensation or muscle weakness in the extremities (peripheral neuropathy). Clusters of enlarged blood vessels that form small, dark red spots on the skin (angiokeratomas) are a characteristic feature of alpha-N-acetylgalactosaminidase deficiency type II.

Type III is the intermediate form of alpha-N-acetylgalactosaminidase deficiency. People with type III may show a variety of signs and symptoms, including developmental, speech, and language delays; seizures that begin in infancy; and features of autism spectrum disorder that appear in childhood. Autism spectrum disorder is characterised by impaired communication and socialization skills. People with type III may also have skeletal signs and symptoms, such as pain in the lower back, hips, and knees. Wear on the cartilage (disks) and bones of the neck (cervical spondylosis) and a cyst-like collection of cerebrospinal fluid that forms in the spinal cord (syringohydromyelia) have also been reported.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Other names

Alpha-galactosidase B deficiency

Alpha-galNAc deficiency, Schindler type

Alpha-N-acetylgalactosaminidase deficiency

Alpha-NAGA deficiency

Angiokeratoma corporis diffusum-glycopeptiduria

GALB deficiency

Kanzaki disease

Lysosomal glycoaminoacid storage disease-angiokeratoma corporis diffusum

NAGA deficiency type I

NAGA deficiency type II

NAGA deficiency type III

Neuroaxonal dystrophy, Schindler type

Neuronal axonal dystrophy, Schindler type

Schindler disease type I

Schindler disease type II

Schindler disease type III

Patient picks for Genetic conditions

Related patient information and medicines

Liver function tests

Patient information leaflet

Liver function tests

Liver function tests are a set of blood tests commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. The pattern of the liver function tests can give a clue to the cause and can allow early detection of unsuspected.

Liver failure

Patient information leaflet

Liver failure

Diseases of the veins in the liver Some diseases (for example, Budd-Chiari syndrom... Metabolic diseases Some rare metabolic diseases may cause acute liver failure. These include haemochromatosis Haemochromatosis , alpha-1 antitrypsin deficiency Alpha-1 antitrypsin deficiency , Wilson's disease Wilson's disease , fructose intolerance,.

Restless legs syndrome

Patient information leaflet

Restless legs syndrome

No treatment may be needed if symptom... Medication can ease symptoms if the condition is distressing. What is restless legs syndrome. Restless legs syndrome (RLS) is sometimes called Willis-Ekbom disease after the doctors who first described it. It is a condition where you have an urge to move your legs. This is usually caused by an uncomfortable.

Gastrointestinal malabsorption

Patient information leaflet

Gastrointestinal malabsorption

Gastrointestinal malabsorption syndrome means a failure to fully absorb digested foods from the gut (bowel) into your body. There are many different causes. Prolonged intestinal malabsorption may cause problems because of a lack of carbohydrates, proteins, fats, minerals and vitamins that are essential to keep you healthy. The treatment will.

Bronchiectasis

Patient information leaflet

Bronchiectasis

Bronchiectasis is a problem with the lungs, where you cough up lots of phlegm, (sputum): far more than usual. It is usually caused by something that has already affected the lungs, like a bad infection; but sometimes no cause is found. It generally affects older people. There are some good treatments available to keep it under control..

Can I take Folic acid and Glucosamine together?

Patient information leaflet

Can I take Folic acid and Glucosamine together?

It is generally considered safe to take these two supplements together. Why this happens Folic acid (a B vitamin) and glucosamine (an amino sugar) are processed by the body through different pathways. They do not compete for absorption in the gut, nor do they interfere with how the liver breaks down or the kidneys remove each substance. Our.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 14 Mar 2025 | Latest version
  • 1 Mar 2025 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.